Literature DB >> 14500679

p21-activated kinase 2 in neutrophils can be regulated by phosphorylation at multiple sites and by a variety of protein phosphatases.

Qian Zhan1, Qingyuan Ge, Taisuke Ohira, Thomas Van Dyke, John A Badwey.   

Abstract

The p21-activated kinase(Pak) 2 undergoes rapid autophosphorylation/activation in neutrophils stimulated with a variety of chemoattractants (e.g., fMLP). Phosphorylation within the activation loop (Thr(402)) and inhibitory domain (Ser(141)) is known to increase the activity of Pak in vitro, whereas phosphorylation within the Nck (Ser(20)) and Pak-interacting guanine nucleotide exchange factor (Ser(192) and Ser(197)) binding sites blocks the interactions of Pak 2 with these proteins. A panel of phosphospecific Abs was used to investigate the phosphorylation of Pak 2 in neutrophils at these sites. Pak 2 underwent rapid (< or =15 s) phosphorylation at Ser(20), Ser(192/197), and Thr(402) in neutrophils stimulated with fMLP. Phosphorylation at Ser(192/197) and Thr(402) were highly transient events, whereas that at Ser(20) was more persistent. In contrast, Pak 2 was constitutively phosphorylated at Ser(141) in unstimulated neutrophils and phosphorylation at this site was less sensitive to cell stimulation than at other residues. Studies with selective inhibitors suggested that a variety of phosphatases might be involved in the rapid dephosphorylation of Pak 2 at Thr(402) in stimulated neutrophils. This was consistent with biochemical studies which showed that the activation loop of GST-Pak 3, which is homologous to that in Pak 2, was a substrate for protein phosphatase 1, 2A, and a Mg(2+)/Mn(2+)-dependent phosphatase(s) which exhibited properties different from those of the conventional isoforms of protein phosphatase 2C. The data indicate that Pak 2 undergoes a complex pattern of phosphorylation in neutrophils and that dephosphorylation at certain sites may involve multiple protein phosphatases that exhibit distinct modes of regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500679     DOI: 10.4049/jimmunol.171.7.3785

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

2.  Rac1-induced cell migration requires membrane recruitment of the nuclear oncogene SET.

Authors:  Jean Paul ten Klooster; Ingrid v Leeuwen; Nina Scheres; Eloise C Anthony; Peter L Hordijk
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

3.  Blocking p21-activated kinase reduces lipopolysaccharide-induced acute lung injury by preventing polymorphonuclear leukocyte infiltration.

Authors:  Jörg Reutershan; Rebecca Stockton; Alexander Zarbock; Gail W Sullivan; Daniel Chang; David Scott; Martin A Schwartz; Klaus Ley
Journal:  Am J Respir Crit Care Med       Date:  2007-02-22       Impact factor: 21.405

Review 4.  p21-Activated Kinases in Thyroid Cancer.

Authors:  Luis Bautista; Christina M Knippler; Matthew D Ringel
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

5.  Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites.

Authors:  Jason D Hoffert; Trairak Pisitkun; Guanghui Wang; Rong-Fong Shen; Mark A Knepper
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

6.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

Review 7.  Regulation of cardiac excitation and contraction by p21 activated kinase-1.

Authors:  Yunbo Ke; Ming Lei; R John Solaro
Journal:  Prog Biophys Mol Biol       Date:  2009-01-24       Impact factor: 3.667

8.  PAK is regulated by PI3K, PIX, CDC42, and PP2Calpha and mediates focal adhesion turnover in the hyperosmotic stress-induced p38 pathway.

Authors:  Perry M Chan; Louis Lim; Edward Manser
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

9.  ER-localized bestrophin 1 activates Ca2+-dependent ion channels TMEM16A and SK4 possibly by acting as a counterion channel.

Authors:  René Barro-Soria; Fadi Aldehni; Joana Almaça; Ralph Witzgall; Rainer Schreiber; Karl Kunzelmann
Journal:  Pflugers Arch       Date:  2009-10-13       Impact factor: 3.657

Review 10.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.